The interactive metabolism effect of oxcarbazepine coadministered with tricyclic antidepressant therapy for OCD symptoms.
Baird
Pryor
P
D000927:Anticonvulsants / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D002220:Carbamazepine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D004347:Drug Interactions; D006801:Humans; D008297:Male; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy / Q000378:metabolism*; D000078330:Oxcarbazepine; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy
D000927:Anticonvulsants; D000929:Antidepressive Agents, Tricyclic; D002220:Carbamazepine; D000078330:Oxcarbazepine